The firm presented its proposal for emergency use authorization of COVID19 mRNA Vaccine BNT162b before the committee. The committee noted that incidents of palsy, anaphylaxis and other SAE’s have been reported during post marketing and the causality of the events with the vaccine is being...
0 Comments
1 Shares
200 Views
Sponsored
We are now 100% funded for April. I am matching donations dollar for dollar this month. Thanks to everyone who helped out. 🥰